Compositions and methods for the inhibition of cripto/grp78...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/18 (2006.01) A61P 35/00 (2006.01) C12N 15/11 (2006.01)

Patent

CA 2743057

The present invention provides methods compositions and methods for treating a hyperproliferative disease comprising disrupting Cripto/GRP78 complex formation in a hyperproliferative cell. In certain embodiments, an antibody and/or siRNA may be used to inhibit Cripto/GRP78 binding, optionally coupled with other cancer therapies. Also provided are methods for identifying therapeutic compounds which can selectively inhibit Cripto/GRP78 binding.

La présente invention porte sur des compositions et des méthodes permettant de traiter une maladie hyperproliférative, comprenant l'interruption de la formation du complexe Cripto/GRP78 dans une cellule hyperproliférative. Dans certains modes de réalisation, un anticorps et/ou un ARNsi peuvent être utilisés pour inhiber la liaison de Cripto/GRP78, facultativement couplés à d'autres thérapies anticancéreuses. L'invention porte également sur des procédés permettant d'identifier des composés thérapeutiques qui peuvent sélectivement inhiber la liaison de Cripto/GRP78.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for the inhibition of cripto/grp78... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for the inhibition of cripto/grp78..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the inhibition of cripto/grp78... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1570627

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.